CN106830473A - The advanced oxidization method of NSAIDs in a kind of ultraviolet hydrogen peroxide removal sewage - Google Patents
The advanced oxidization method of NSAIDs in a kind of ultraviolet hydrogen peroxide removal sewage Download PDFInfo
- Publication number
- CN106830473A CN106830473A CN201710151084.2A CN201710151084A CN106830473A CN 106830473 A CN106830473 A CN 106830473A CN 201710151084 A CN201710151084 A CN 201710151084A CN 106830473 A CN106830473 A CN 106830473A
- Authority
- CN
- China
- Prior art keywords
- sewage
- nsaids
- hydrogen peroxide
- concentration
- ultraviolet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000010865 sewage Substances 0.000 title claims abstract description 76
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 title claims abstract description 75
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 title claims abstract description 75
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 26
- 238000007254 oxidation reaction Methods 0.000 title claims abstract description 17
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 17
- 230000001954 sterilising effect Effects 0.000 claims abstract description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 238000001514 detection method Methods 0.000 claims description 21
- 239000006228 supernatant Substances 0.000 claims description 20
- 238000012360 testing method Methods 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 12
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 10
- 229910052753 mercury Inorganic materials 0.000 claims description 10
- 239000003002 pH adjusting agent Substances 0.000 claims description 10
- 239000008394 flocculating agent Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000010453 quartz Substances 0.000 claims description 9
- 230000003637 steroidlike Effects 0.000 claims description 9
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- GFLJTEHFZZNCTR-UHFFFAOYSA-N 3-prop-2-enoyloxypropyl prop-2-enoate Chemical compound C=CC(=O)OCCCOC(=O)C=C GFLJTEHFZZNCTR-UHFFFAOYSA-N 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 238000013019 agitation Methods 0.000 claims description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 5
- 229910052782 aluminium Inorganic materials 0.000 claims description 5
- DLGYNVMUCSTYDQ-UHFFFAOYSA-N azane;pyridine Chemical compound N.C1=CC=NC=C1 DLGYNVMUCSTYDQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 238000005345 coagulation Methods 0.000 claims description 5
- 230000015271 coagulation Effects 0.000 claims description 5
- 230000000249 desinfective effect Effects 0.000 claims description 5
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 5
- 239000011790 ferrous sulphate Substances 0.000 claims description 5
- 238000005189 flocculation Methods 0.000 claims description 5
- 230000016615 flocculation Effects 0.000 claims description 5
- 239000007789 gas Substances 0.000 claims description 5
- 230000005484 gravity Effects 0.000 claims description 5
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 5
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 claims description 5
- 229920002717 polyvinylpyridine Polymers 0.000 claims description 5
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims description 5
- 229940080818 propionamide Drugs 0.000 claims description 5
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 4
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
- 235000019398 chlorine dioxide Nutrition 0.000 claims 1
- OSVXSBDYLRYLIG-UHFFFAOYSA-N chlorine dioxide Inorganic materials O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 claims 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 claims 1
- 235000010265 sodium sulphite Nutrition 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- 235000011149 sulphuric acid Nutrition 0.000 claims 1
- 238000009303 advanced oxidation process reaction Methods 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 239000007800 oxidant agent Substances 0.000 description 7
- 230000001590 oxidative effect Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 5
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 5
- 239000003708 ampul Substances 0.000 description 5
- 239000000356 contaminant Substances 0.000 description 5
- 229960001259 diclofenac Drugs 0.000 description 5
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229960002009 naproxen Drugs 0.000 description 5
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002552 multiple reaction monitoring Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- -1 Hydroxyl radical free radical Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- SXERGJJQSKIUIC-UHFFFAOYSA-N 2-Phenoxypropionic acid Chemical compound OC(=O)C(C)OC1=CC=CC=C1 SXERGJJQSKIUIC-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical class COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 241001494246 Daphnia magna Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 description 1
- 241000276569 Oryzias latipes Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 231100000584 environmental toxicity Toxicity 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229960001929 meloxicam Drugs 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- HYWYRSMBCFDLJT-UHFFFAOYSA-N nimesulide Chemical compound CS(=O)(=O)NC1=CC=C([N+]([O-])=O)C=C1OC1=CC=CC=C1 HYWYRSMBCFDLJT-UHFFFAOYSA-N 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 230000015843 photosynthesis, light reaction Effects 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical compound O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 229960000371 rofecoxib Drugs 0.000 description 1
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F9/00—Multistage treatment of water, waste water or sewage
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/30—Treatment of water, waste water, or sewage by irradiation
- C02F1/32—Treatment of water, waste water, or sewage by irradiation with ultraviolet light
- C02F1/325—Irradiation devices or lamp constructions
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/5236—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using inorganic agents
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/52—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
- C02F1/54—Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
- C02F1/56—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/66—Treatment of water, waste water, or sewage by neutralisation; pH adjustment
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/722—Oxidation by peroxides
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/76—Treatment of water, waste water, or sewage by oxidation with halogens or compounds of halogens
- C02F1/763—Devices for the addition of such compounds in gaseous form
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/34—Organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/36—Organic compounds containing halogen
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Physical Water Treatments (AREA)
Abstract
The invention discloses a kind of advanced oxidization method of NSAIDs in ultraviolet hydrogen peroxide removal sewage, sewage is passed sequentially through into settling pit, second pond, carry out the separation of bulky grain;The sewage for separating bulky grain is passed through the H that mass fraction is 30% is added in Photoreactor2O2Solution, opens UV lamp pipe, carries out oxidation reaction, is then carried out disinfection by sterilization pool, finally detects the content of NSAIDs in sewage;The present invention uses UV advanced oxidation processes, effectively removes the NSAIDs in sewage, sewage discharge is reached requirement, reduces the environmental risk of NSAIDs.This method has the advantages that equipment is simple, easy to operate, economical rationality, compensate for the deficiency of current sewage purification process.
Description
Technical field
The present invention relates to NSAIDs processing technology field, a kind of ultraviolet hydrogen peroxide removal sewage is specifically related to
The advanced oxidization method of middle NSAIDs.
Background technology
NSAIDs is wide variety of anti-inflammation drugs in class clinic, and the annual consumption of China is only second to anti-infective
Medicine.Can be divided into following species by chemical constitution NSAIDs:Formic acid class, such as aspirin;Acetic acid class, such as Diclofenac,
Indomethacin;Phenoxy propionic acid, such as brufen, naproxen;Former times health class, such as piroxicam, Meloxicam;Former times dry goods, such as celecoxib,
Rofecoxib;Pyrazolone, such as phenylbutazone, aminopyrine;Other, such as aulin.These medicines can not be complete after being taken through people
Portion is absorbed by the body, and remainder can be excreted with urine, excrement and enter environment.And sewage treatment plant is it mainly gathers
Ground.Used as a class emerging pollutant, existing toxicity research shows that NSAIDs can be to medaka, zebra fish, Daphnia magna, floating
The aquatiles such as duckweed produce eco-toxicity.Therefore, how effectively removal NSAIDs is increasingly received in sewage disposal system
To the concern of people.
The advanced treatment process of sewage studies different depth science and engineerings as the important step for ensureing sewage safety dumping
Skill is significant to the effect that NSAIDs is removed.It is charcoal absorption, mixed in some current advanced treatment process
Retrogradation shallow lake, cholorination are undesirable to NSAIDs removal effect.Hydrogen peroxide does not remove effect to NSAIDs
Really, ozone high grade oxidation technique actual sewage treatment plant add dosage and time of contact under, also can only partly go unless steroid
Body anti-inflammatory agent.The NSAIDs in actual sewage is removed using UV advanced oxidation processes there is no systematic research.
The content of the invention
Present invention solves the technical problem that being to provide a kind of height of NSAIDs in ultraviolet hydrogen peroxide removal sewage
Level method for oxidation, the method has more excellent removal effect, can effectively remove sewage for Diclofenac, brufen, naproxen
In NSAIDs.
The technical scheme is that:
The advanced oxidization method of NSAIDs, comprises the following steps in a kind of ultraviolet hydrogen peroxide removal sewage:
(1) take sewage supernatant 3-5 times at random, to NSAIDs Concentration Testing in supernatant, and record detection number
According to;
(2) sewage is passed through settling pit, flocculant is added in settling pit, held than being 10-100g with the matter of sewage:1L,
Settling pit has variable speed stirrer, first 5-15min coagulations is quickly stirred with the rotating speed of 150-250r/min, then with 60-80r/min
Rotating speed low rate mixing 5-15min flocculations, subsequent sewage adds pH adjusting agent gravity or so is lower, makes dirt from second pond is flow to
The pH value of water is less than 8.0, and more than 2 μm particles are filtered by second pond;
(3) supernatant after second pond is separated is entered in Photoreactor by water pump, to adding mass concentration in supernatant
It is 30% H2O2Solution so that H2O2It is (1-100) with the molar concentration rate of NSAIDs:1, then use uviol lamp
Photo-irradiation treatment is carried out, light application time is 5-10min, keep uniform by electromagnetic agitation;The molar concentration being eventually adding is 0.1mM
Na2SO3;
(4) step (3) gained sewage is entered into sterilization pool, to being passed through ClO in sterilization pool2Gas, makes effective chlorine in sewage
Content is 5-20ppm;The random water sample for taking sterilization pool carries out the detection of NSAIDs, testing result is recorded, with step
The testing result of one record compares analysis, finally by the Chinese effluent of disinfecting tank.
Further, the flocculant described in step (1) is organic flocculant and inorganic flocculating agent with mass ratio 1:1-1.5's
Ratio mixing gained, during the organic flocculant is poly- propionamide, PDDA, polyvinyl pyridine ammonium
One or two mixing, described inorganic flocculating agent is one or more in poly-aluminum ferric chloride sulfate, polyaluminium chloride, ferrous sulfate
Mixing, can generate larger floccule body and precipitate, effective removal sewage various suspension and macromolecular substances.
Further, the pH adjusting agent described in step (1) is the H of concentration 0.05mol/L2SO4, make the sewage be in by regulation
Acid or alkalescent, it is to avoid corrosion Photoreactor.
Further, the Photoreactor described in step (2) mainly uses silica glass material, center vertical to place quartz ampoule
Uviol lamp is placed in set, quartz ampoule, quartz glass is high to the transmissivity of ultraviolet light, promote H2O2Decompose and produce OH.
Further, described uviol lamp is 22W low pressure mercury lamps, and emission wavelength is 254nm, quartzy tube wall outer wall ultraviolet light
Intensity is 1.35mW/cm2。
Further, the detection method of NSAIDs is efficient liquid phase in the sewage described in step (1), step (4)
Chromatogram-tandem mass spectrometry, comprises the following steps that:
(A) three kinds of NSAIDs are concentrated and purified:
A () uses 3mL equilibrium methanol CNW HLB pillars;
B () uses 3mL pure water CNW HLB pillars;
C 50mL water samples are passed through CNW HLB pillars by () with the speed of 1mL/min;
D () washs CNW HLB pillars again with the methyl alcohol of 3mL 5%;
E () is eluted with 6mL methanol solutions, wash-out liquid nitrogen blows and is settled to 1mL, 4 DEG C of refrigerators is stored in, to treat follow-up upper machine examination
Survey;
(B) LC-MS detection non-steroidal anti-inflammatory concentration.
Further, the clearance of NSAIDs=(1-Ct/C0) × 100%, C0It is initial concentration, CtIt is reaction
Non-steroidal anti-inflammatory concentration during time t.During dynamics simulation, ordinate is Ln (C0/Ct), wherein C0It is initial concentration, CtFor
Non-steroidal anti-inflammatory concentration during reaction time t, the NSAIDs of measure includes Diclofenac, brufen, naproxen.
Beneficial effects of the present invention are:
1st, the present invention uses UV advanced oxidation processes, by the way that some oxidants etc. are catalytically decomposed, produces oxidisability extremely strong
Hydroxyl radical free radical (OH) so that in water multiple pollutant decompose or mineralising, can effectively remove the non-steroidal anti-inflammatory in sewage
Medicine, makes sewage discharge reach requirement, it is to avoid pollution to environment;
2nd, method of the present invention high treating effect, it is also more economical, with equipment is simple, easy to operate, expense is cheap etc.
Advantage, and pollution-free, stability is high;
3rd, the present invention compensate for the deficiency of dirty purification technique at present, improve prior art it is poor to NSAIDs effect,
The shortcoming of fluctuation of service, has filled up the blank both at home and abroad about NSAIDs removal technology in water source.
Brief description of the drawings
Fig. 1 is operational flowchart of the invention;
Fig. 2 is the influence graph of a relation that light application time is degraded to NSAIDs;
Fig. 3 is influence graph of a relation of the oxidant concentration to NSAIDs removal effect.
Specific embodiment
To make the purpose, technical scheme and advantage of the embodiment of the present invention clearer, below in conjunction with accompanying drawing of the invention,
Technical scheme in the embodiment of the present invention is clearly and completely described, it is clear that described embodiment is the present invention one
Divide embodiment, rather than whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art are not making
The every other embodiment obtained under the premise of creative work, belongs to the scope of protection of the invention.
The present invention is further elaborated with conjunction with specific embodiment.
The embodiment is with the two stage biological water outlet of Nanjing municipal sewage plant as object is carried out.
Embodiment 1:The advanced oxidization method of NSAIDs in a kind of ultraviolet hydrogen peroxide removal sewage, including it is following
Step:
(1) sewage supernatant is taken 3 times at random, to NSAIDs Concentration Testing in supernatant, and recording detection data,
And average;
(2) sewage is passed through settling pit, flocculant is added in settling pit, held than being 20g with the matter of sewage:1L, desilting
There is variable speed stirrer in pond, first 5min coagulations is quickly stirred with the rotating speed of 150r/min, then with the rotating speed low rate mixing of 60r/min
5min flocculates, and subsequent sewage is lower from second pond is flow in gravity or so, and addition pH adjusting agent makes the pH value of sewage be 5.0, passes through
Second pond filters more than 2 μm particles;Flocculant is organic flocculant and inorganic flocculating agent with mass ratio 1:1 ratio mixing institute
, organic flocculant is poly- propionamide, PDDA, the two kinds of mixing of polyvinyl pyridine ammonium, inorganic flocculation
Agent is the mixing in bisgallic acid polymeric ferric aluminum, polyaluminium chloride, ferrous sulfate;PH adjusting agent is the H of concentration 0.05mol/L2SO4;
(3) supernatant after second pond is separated is entered in Photoreactor by water pump, to adding mass concentration in supernatant
It is 30% H2O2Solution so that H2O2It is 30 with the molar concentration rate of NSAIDs:1, then carry out light using uviol lamp
According to treatment, light application time is 5min, keeps uniform by electromagnetic agitation;The molar concentration being eventually adding is the Na of 0.1mM2SO3;
Photoreactor mainly uses silica glass material, and center vertical is placed and uviol lamp is placed in quartz pipe sleeve, quartz ampoule, by ultraviolet
Lamp sends ultraviolet light;Uviol lamp is 22W low pressure mercury lamps, and emission wavelength is 254nm, and quartzy tube wall outer wall ultraviolet ray intensity is
1.35mW/cm2;
(4) step (3) gained sewage is entered into sterilization pool, to being passed through ClO in sterilization pool2Gas, makes effective chlorine in sewage
Content is 5ppm;The random water sample for taking sterilization pool carries out the detection of NSAIDs, and testing result is recorded, and remembers with step one
The testing result of record is compared analysis, and the water outlet of disinfecting tank finally is drained into municipal sewage pipe network;
In a kind of sewage described in step (1), step (4) detection method of NSAIDs be high performance liquid chromatography-
Tandem mass spectrometry, comprises the following steps that:
(A) three kinds of NSAIDs are concentrated and purified:
A () uses 3mL equilibrium methanol CNW HLB pillars;
B () uses 3mL pure water CNW HLB pillars;
C 50mL water samples are passed through CNW HLB pillars by () with the speed of 1mL/min;
D () washs CNW HLB pillars again with the methyl alcohol of 3mL 5%;
E () is eluted with 6mL methanol solutions, wash-out liquid nitrogen blows and is settled to 1mL, 4 DEG C of refrigerators is stored in, to treat follow-up upper machine examination
Survey;
(B) LC-MS detection non-steroidal anti-inflammatory concentration.
Embodiment 2:The advanced oxidization method of NSAIDs in a kind of ultraviolet hydrogen peroxide removal sewage, including it is following
Step:
(1) sewage supernatant is taken 4 times at random, to NSAIDs Concentration Testing in supernatant, and recording detection data;
(2) sewage is passed through settling pit, flocculant is added in settling pit, held than being 50g with the matter of sewage:1L, desilting
There is variable speed stirrer in pond, first quickly stirs 10min coagulations with the rotating speed of 200r/min, is then stirred at a slow speed with the rotating speed of 70r/min
10min flocculations are mixed, subsequent sewage, from second pond is flow to, adds pH adjusting agent under gravity or so, make the pH value of sewage be 7.0,
More than 2 μm particles are filtered by second pond;Flocculant is organic flocculant and inorganic flocculating agent with mass ratio 1:1.2 ratio is mixed
Gained is closed, the organic flocculant is two kinds in poly- propionamide, PDDA, polyvinyl pyridine ammonium to be mixed
Close, described inorganic flocculating agent is the various mixing in bisgallic acid polymeric ferric aluminum, polyaluminium chloride, ferrous sulfate;PH adjusting agent is dense
Spend the H of 0.05mol/L2SO4;
(3) supernatant after second pond is separated is entered in Photoreactor by water pump, to adding mass concentration in supernatant
It is 30% H2O2Solution so that H2O2It is 50 with the molar concentration rate of NSAIDs:1, then carry out light using uviol lamp
According to treatment, light application time is 5-10min, keeps uniform by electromagnetic agitation;The molar concentration being eventually adding is 0.1mM's
Na2SO3;Photoreactor mainly uses silica glass material, center vertical to place and uviol lamp is placed in quartz pipe sleeve, quartz ampoule, lead to
Cross uviol lamp and send ultraviolet light;Uviol lamp is 22W low pressure mercury lamps, and emission wavelength is 254nm, quartzy tube wall outer wall ultraviolet ray intensity
It is 1.35mW/cm2;
(4) step (3) gained sewage is entered into sterilization pool, to being passed through ClO in sterilization pool2Gas, makes effective chlorine in sewage
Content is 10ppm;The random water sample for taking sterilization pool carries out the detection of NSAIDs, testing result is recorded, with step one
The testing result of record is compared analysis, and the water outlet of disinfecting tank finally is drained into municipal sewage pipe network.
The detection method of NSAIDs is high performance liquid chromatography-series connection in sewage described in step (1), step (4)
Mass spectrography, comprises the following steps that:
(A) three kinds of NSAIDs are concentrated and purified:
A () uses 3mL equilibrium methanol CNW HLB pillars;
B () uses 3mL pure water CNW HLB pillars;
C 50mL water samples are passed through CNW HLB pillars by () with the speed of 1mL/min;
D () washs CNW HLB pillars again with the methyl alcohol of 3mL 5%;
E () is eluted with 6mL methanol solutions, wash-out liquid nitrogen blows and is settled to 1mL, 4 DEG C of refrigerators is stored in, to treat follow-up upper machine examination
Survey;
(B) LC-MS detection non-steroidal anti-inflammatory concentration.
Embodiment 3:The advanced oxidization method of NSAIDs in a kind of ultraviolet hydrogen peroxide removal sewage, including it is following
Step:
(1) sewage supernatant is taken 5 times at random, to NSAIDs Concentration Testing in supernatant, and recording detection data;
(2) sewage is passed through settling pit, flocculant is added in settling pit, held than being 100g with the matter of sewage:1L, desilting
There is variable speed stirrer in pond, first quickly stirs 10min coagulations with the rotating speed of 250r/min, is then stirred at a slow speed with the rotating speed of 80r/min
5-15min flocculations are mixed, subsequent sewage flow to second pond, addition pH adjusting agent certainly under gravity or so, and the pH value for making sewage is
8.0, more than 2 μm particles are filtered by second pond;Flocculant is organic flocculant and inorganic flocculating agent with mass ratio 1:1.5 ratio
Example mixing gained, the organic flocculant is two in poly- propionamide, PDDA, polyvinyl pyridine ammonium
Mixing is planted, described inorganic flocculating agent is the various mixing in bisgallic acid polymeric ferric aluminum, polyaluminium chloride, ferrous sulfate;PH adjusting agent
It is the H of concentration 0.05mol/L2SO4;
(4) supernatant after second pond is separated is entered in Photoreactor by water pump, to adding mass concentration in supernatant
It is 30% H2O2Solution so that H2O2It is 100 with the molar concentration rate of NSAIDs:1, then carried out using uviol lamp
Photo-irradiation treatment, light application time is 10min, keeps uniform by electromagnetic agitation;The molar concentration being eventually adding is 0.1mM's
Na2SO3;Photoreactor mainly uses silica glass material, center vertical to place and uviol lamp is placed in quartz pipe sleeve, quartz ampoule, lead to
Cross uviol lamp and send ultraviolet light;Uviol lamp is 22W low pressure mercury lamps, and emission wavelength is 254nm, quartzy tube wall outer wall ultraviolet ray intensity
It is 1.35mW/cm2;
(4) step (3) gained sewage is entered into sterilization pool, to being passed through ClO in sterilization pool2Gas, makes effective chlorine in sewage
Content is 20ppm;The random water sample for taking sterilization pool carries out the detection of NSAIDs, testing result is recorded, with step one
The testing result of record is compared analysis, and the water outlet of disinfecting tank finally is drained into municipal sewage pipe network.
The detection method of NSAIDs is high performance liquid chromatography-series connection in sewage described in step (1), step (4)
Mass spectrography, comprises the following steps that:
(A) three kinds of NSAIDs are concentrated and purified:
A () uses 3mL equilibrium methanol CNW HLB pillars;
B () uses 3mL pure water CNW HLB pillars;
C 50mL water samples are passed through CNW HLB pillars by () with the speed of 1mL/min;
D () washs CNW HLB pillars again with the methyl alcohol of 3mL 5%;
E () is eluted with 6mL methanol solutions, wash-out liquid nitrogen blows and is settled to 1mL, 4 DEG C of refrigerators is stored in, to treat follow-up upper machine examination
Survey;
(B) LC-MS detection non-steroidal anti-inflammatory concentration.
First, embodiment interpretation of result:
(1) 0.22 μm of composite fibre membrane filtration of 500mL water samples is taken, is stored in 4 DEG C of refrigerators to treat follow-up consolidating after filtering
Phase extracting operation and NSAIDs concentration mensuration therewith.± standard deviation of averaging is analyzed.It is simple real
Test flow as shown in Figure 1.
(A) three kinds of NSAIDs are concentrated and purified
CNW HLB (60mg, 3mL) water phase that the solid-phase extraction column of selection is provided for Town in Shanghai spectrum --- it is organic balanced small
Post.Comprise the following steps that:
A () uses 3mL equilibrium methanol CNW HLB pillars;
B () uses 3mL pure water CNW HLB pillars;
C 50mL water samples are passed through CNW HLB pillars by () with the speed of 1mL/min;
D () washs CNW HLB pillars again with the methyl alcohol of 3mL 5%;
E () is eluted with 6mL methanol solutions, wash-out liquid nitrogen blows and is settled to 1mL, 4 DEG C of refrigerators is stored in, to treat follow-up upper machine examination
Survey;
(B) LC-MS detection non-steroidal anti-inflammatory concentration:
Selected LC-MS instrument is the Xevo TQ-S UPLC-MS LC-MS instrument of Waters, US, is adopted
With electric spray ion source (ESI), negative electricity is from multiple-reaction monitoring pattern (MRM).The parameter of multiple-reaction monitoring is shown in Table 1.
The multiple-reaction monitoring parameter of the NSAIDs of table 1.
The chromatographic column that liquid phase separation is selected is Acquity UPLC BEH C18 chromatographic columns (2.1 × 50mm, 1.7um), post
Temperature is maintained at 30 DEG C.Selected mobile phase is water (A) and methyl alcohol (B).Mobile phase uses preceding ultrasound degassing.Liquid phase flow rate is
0.1mL/min, A Phase Proportion 20%, B Phase Proportions 80%, isocratic elution 5min.Sample size is 10 μ L, is entered using automatic sampler
Sample.
2nd, NSAIDs clearance analysis
The concentration unit of NSAIDs herein is μ g/L
The clearance of NSAIDs=(1-Ct/C0) × 100%, C0It is initial concentration, CtDuring for reaction time t
Non-steroidal anti-inflammatory concentration.During dynamics simulation, ordinate is Ln (C0/Ct), wherein C0It is initial concentration, CtIt is reaction time t
When non-steroidal anti-inflammatory concentration, the NSAIDs of measure includes Diclofenac, brufen, naproxen.
Understood through analysis:
1st, the influence that UV light application times are removed to target contaminant
Light application time is as shown in Figure 2 to the influence that three kinds of NSAIDs are degraded.Diclofenac, brufen, naproxen
Three kinds of NSAIDs can under the irradiation of ultraviolet light direct photolysis, the degradation reaction of three kinds of NSAIDs is
First-order kinetics, reaction rate constant is respectively 5.04 × 10-3s-1、0.291×10-3s-1、0.208×10-3s-1。
2、H2O2With the influence that the molar concentration of NSAIDs compares target contaminant removal
As shown in figure 3, when irradiating 5min using 22W low pressure mercury lamps, H2O2With the molar concentration of NSAIDs 1:1
~100:When 1, with the increase of oxidant concentration, the clearance of all target contaminants increases.In general, working as H2O2It is dense
When spending big, can be reacted so as to consume OH with the OH for producing, so oxidant dosage has optimal value.But in present case
Three kinds of NSAIDs are hard-degraded substance, and with the increase of oxidant dosage, clearance is also stepped up.Consider
The economy of actual process operation, selection 100:1 oxidant dosage is optimum ad dition amount.Use UV/H2O2Process degradation is non-
During steroidal anti-inflammatory medicine, the degradation rate of three kinds of materials all improves a lot, and 5min clearances can reach 90%.
3rd, the influence that the intensity of light source is removed to target contaminant
Common ultraviolet light source, respectively 22W low pressure mercury lamps and 300W in two kinds of UV/AOP techniques of this experimental selection
Medium pressure mercury lamp, 100:1 oxidant dosage, under 5 minutes reaction conditions, the removal effect to target contaminant is as shown in table 2.
When using 22W low pressure mercury lamps, there is good removal effect to three kinds of NSAIDs, considered from energy consumption angle, choosing
22W low pressure mercury lamps are selected as light source.
2. two kinds of light sources of table are contrasted to the removal effect of NSAIDs
In sum, the method for the present invention can effectively remove the NSAIDs in sewage.It is indicated above that present invention side
Various components and parameter in method are optimal selections, are capable of achieving the optimum efficiency of the inventive method.
The above, is only presently preferred embodiments of the present invention, is not the limitation for making other forms to the present invention, is appointed
What those skilled in the art changed possibly also with the technology contents of the disclosure above or be modified as equivalent variations etc.
Effect embodiment.But it is every without departing from technical solution of the present invention content, according to technical spirit of the invention to above example institute
Any simple modification, equivalent variations and the remodeling made, still fall within the protection domain of technical solution of the present invention.
Claims (6)
1. in a kind of ultraviolet hydrogen peroxide removal sewage NSAIDs advanced oxidization method, it is characterised in that including with
Lower step:
(1) sewage supernatant is taken 3-5 times at random, to NSAIDs Concentration Testing in supernatant, and recording detection data;
(2) sewage is passed through settling pit, flocculant is added in settling pit, held than being 10-100g with the matter of sewage:1L, desilting
There is variable speed stirrer in pond, first quickly stirs 5-15min coagulations with the rotating speed of 150-250r/min, then turning with 60-80r/min
Fast low rate mixing 5-15min flocculations, subsequent sewage is lower from second pond is flow in gravity or so, and addition pH adjusting agent makes sewage
PH value is less than 8.0, and more than 2 μm particles are filtered by second pond;
(3) supernatant after second pond is separated is entered in Photoreactor by water pump, is to mass concentration is added in supernatant
30% H2O2 solution so that H2O2 is (1-100) with the molar concentration rate of NSAIDs:1, then entered using uviol lamp
Row photo-irradiation treatment, light application time is 5-10min, keeps uniform by electromagnetic agitation;The molar concentration being eventually adding is 0.1mM's
Na2SO3;
(4) step (3) gained sewage is entered into sterilization pool, to ClO2 gases are passed through in sterilization pool, makes available chlorine content in sewage
It is 5-20ppm;The random water sample for taking sterilization pool carries out the detection of NSAIDs, and testing result is recorded, and remembers with step one
The testing result of record compares analysis, finally by the Chinese effluent of disinfecting tank.
2. in a kind of ultraviolet hydrogen peroxide removal sewage as claimed in claim 1 NSAIDs advanced oxidization method,
Characterized in that, the flocculant described in step (2) is organic flocculant and inorganic flocculating agent with mass ratio 1:The ratio of (1-1.5)
Mixing gained, the organic flocculant is the one kind in poly- propionamide, PDDA, polyvinyl pyridine ammonium
Or two kinds of mixing, described inorganic flocculating agent is mixed one or more in bisgallic acid polymeric ferric aluminum, polyaluminium chloride, ferrous sulfate
Close.
3. in a kind of ultraviolet hydrogen peroxide removal sewage as claimed in claim 1 NSAIDs advanced oxidization method,
PH adjusting agent described in step (2) is the H2SO4 of concentration 0.05mol/L.
4. in a kind of ultraviolet hydrogen peroxide removal sewage as claimed in claim 1 NSAIDs advanced oxidization method,
Characterized in that, the Photoreactor described in step (3) mainly uses silica glass material, center vertical to place quartz pipe sleeve, stone
Uviol lamp is placed in English pipe, ultraviolet light is sent by uviol lamp.
5. in a kind of ultraviolet hydrogen peroxide removal sewage as described in claim 1-4 NSAIDs advanced oxidation side
Method, it is characterised in that described uviol lamp is 22W low pressure mercury lamps, and emission wavelength is 254nm, quartzy tube wall outer wall ultraviolet light intensity
It is 1.35mW/cm2 to spend.
6. in a kind of ultraviolet hydrogen peroxide removal sewage as claimed in claim 1 NSAIDs advanced oxidization method,
Characterized in that, the detection method of NSAIDs is high performance liquid chromatography-string in sewage described in step (1), step (4)
Connection mass spectrography, comprises the following steps that:
(A) three kinds of NSAIDs are concentrated and purified:
A () uses 3mL equilibrium methanol CNW HLB pillars;
B () uses 3mL pure water CNW HLB pillars;
C 50mL water samples are passed through CNW HLB pillars by () with the speed of 1mL/min;
D () washs CNW HLB pillars again with the methyl alcohol of 3mL 5%;
E () is eluted with 6mL methanol solutions, wash-out liquid nitrogen blows and is settled to 1mL, 4 DEG C of refrigerators is stored in, to treat follow-up upper machine testing;
(B) LC-MS detection non-steroidal anti-inflammatory concentration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710151084.2A CN106830473A (en) | 2017-03-14 | 2017-03-14 | The advanced oxidization method of NSAIDs in a kind of ultraviolet hydrogen peroxide removal sewage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710151084.2A CN106830473A (en) | 2017-03-14 | 2017-03-14 | The advanced oxidization method of NSAIDs in a kind of ultraviolet hydrogen peroxide removal sewage |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106830473A true CN106830473A (en) | 2017-06-13 |
Family
ID=59144702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710151084.2A Pending CN106830473A (en) | 2017-03-14 | 2017-03-14 | The advanced oxidization method of NSAIDs in a kind of ultraviolet hydrogen peroxide removal sewage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106830473A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110627277A (en) * | 2019-10-24 | 2019-12-31 | 常飞 | Pharmaceutical factory sewage treatment method |
CN111718041A (en) * | 2020-05-09 | 2020-09-29 | 上海大学 | Method for degrading anti-inflammatory drug indomethacin in water body by electron beam irradiation |
CN111762978A (en) * | 2020-07-15 | 2020-10-13 | 南京大学 | UV/H for deeply removing drug micropollutants in sewage2O2Combined biological activated carbon process |
CN115368902A (en) * | 2021-05-18 | 2022-11-22 | 中国石油化工股份有限公司 | Kit with function of degrading organic pollutants and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014097472A (en) * | 2012-11-15 | 2014-05-29 | Swing Corp | Treatment method and treatment apparatus for organic waste water |
CN104193051A (en) * | 2014-09-03 | 2014-12-10 | 苏州中亚油墨有限公司 | Deep purification treatment method for printing ink wastewater |
CN106186476A (en) * | 2016-08-18 | 2016-12-07 | 南京大学 | Artificial sweetening agent acesulfame potassium and the light Fenton method of sucralose in a kind of mineralising sewage |
-
2017
- 2017-03-14 CN CN201710151084.2A patent/CN106830473A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014097472A (en) * | 2012-11-15 | 2014-05-29 | Swing Corp | Treatment method and treatment apparatus for organic waste water |
CN104193051A (en) * | 2014-09-03 | 2014-12-10 | 苏州中亚油墨有限公司 | Deep purification treatment method for printing ink wastewater |
CN106186476A (en) * | 2016-08-18 | 2016-12-07 | 南京大学 | Artificial sweetening agent acesulfame potassium and the light Fenton method of sucralose in a kind of mineralising sewage |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110627277A (en) * | 2019-10-24 | 2019-12-31 | 常飞 | Pharmaceutical factory sewage treatment method |
CN111718041A (en) * | 2020-05-09 | 2020-09-29 | 上海大学 | Method for degrading anti-inflammatory drug indomethacin in water body by electron beam irradiation |
CN111762978A (en) * | 2020-07-15 | 2020-10-13 | 南京大学 | UV/H for deeply removing drug micropollutants in sewage2O2Combined biological activated carbon process |
CN115368902A (en) * | 2021-05-18 | 2022-11-22 | 中国石油化工股份有限公司 | Kit with function of degrading organic pollutants and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Klamerth et al. | Photo-Fenton and modified photo-Fenton at neutral pH for the treatment of emerging contaminants in wastewater treatment plant effluents: a comparison | |
Klamerth et al. | Modified photo-Fenton for degradation of emerging contaminants in municipal wastewater effluents | |
Gernjak et al. | Pilot-plant treatment of olive mill wastewater (OMW) by solar TiO2 photocatalysis and solar photo-Fenton | |
Poblete et al. | Cost estimation of COD and color removal from landfill leachate using combined coffee-waste based activated carbon with advanced oxidation processes | |
Naffrechoux et al. | Sonochemical and photochemical oxidation of organic matter | |
Michael et al. | Utilizing solar energy for the purification of olive mill wastewater using a pilot-scale photocatalytic reactor after coagulation-flocculation | |
Sindelar et al. | Evaluating UV/H2O2, UV/percarbonate, and UV/perborate for natural organic matter reduction from alternative water sources | |
CN106830473A (en) | The advanced oxidization method of NSAIDs in a kind of ultraviolet hydrogen peroxide removal sewage | |
CN106830277A (en) | The advanced oxidization method of NSAIDs in a kind of ultraviolet persulfate removal sewage | |
CN105668880A (en) | Method for controlling chlorinated nitrogenous disinfection byproduct in water | |
CN105692861B (en) | The advanced oxidization method of artificial sweetener in a kind of removal sewage | |
Malato et al. | Coupling solar photo-Fenton and biotreatment at industrial scale: main results of a demonstration plant | |
CN205328814U (en) | Handle alkaline dye wastewater's device | |
Sharma et al. | Studies on degradation of reactive red 135 dye in wastewater using ozone | |
Chin et al. | Greywater treatment by UVC/H2O2 | |
Liu et al. | Synergistically coupling membrane electrochemical reactor with Fenton process to enhance landfill leachate treatment | |
Patel et al. | Ozone microbubble-aided intensification of degradation of naproxen in a plant prototype | |
Monteagudo et al. | Effect of light source on the catalytic degradation of protocatechuic acid in a ferrioxalate-assisted photo-Fenton process | |
Yuan et al. | Degradation of acid pharmaceuticals in the UV/H2O2 process: effects of humic acid and inorganic salts | |
Expósito et al. | Photo-Fenton degradation of a beverage industrial effluent: intensification with persulfate and the study of radicals | |
Alrousan et al. | Evaluation of ozone-based oxidation and solar advanced oxidation treatment of greywater | |
Plakas et al. | Electro-Fenton applications in the water industry | |
Colades et al. | Treatment of thin film transistor-liquid crystal display (TFT-LCD) wastewater by the electro-Fenton process | |
Zhou et al. | Decomplexation efficiency and mechanism of cu (II)–EDTA by H 2 O 2 coupled internal micro-electrolysis process | |
Wang et al. | Evolution of low molecular weight organic compounds during ultrapure water production process: A pilot-scale study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170613 |
|
RJ01 | Rejection of invention patent application after publication |